Commentary: point. Blood pressure-lowering treatment should be offered to all patients regardless of blood pressure.
作者信息
McManus Richard J, Mant Jonathan
机构信息
Primary Care Clinical Sciences, University of Birmingham, Birmingham, UK.
出版信息
J Clin Hypertens (Greenwich). 2009 Dec;11(12):698-701. doi: 10.1111/j.1751-7176.2009.00183.x.
Abstract
摘要
相似文献
1
Commentary: point. Blood pressure-lowering treatment should be offered to all patients regardless of blood pressure.评论：要点。无论血压如何，都应为所有患者提供降压治疗。
J Clin Hypertens (Greenwich). 2009 Dec;11(12):698-701. doi: 10.1111/j.1751-7176.2009.00183.x.
2
3
Importance of blood pressure control in hypertensive patients with coronary heart disease in clinical practice to reduce the risk of stroke.在临床实践中，控制高血压合并冠心病患者的血压对于降低中风风险的重要性。
Stroke. 2009 Jun;40(6):e469; author reply e470. doi: 10.1161/STROKEAHA.108.519686. Epub 2009 Apr 23.
4
Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol.高血压患者心血管疾病的预防：降低血压和胆固醇的作用
QJM. 2002 Dec;95(12):821-6. doi: 10.1093/qjmed/95.12.821.
5
[Blood pressure lowering after stroke].[中风后的血压降低]
Dtsch Med Wochenschr. 2006 Apr 7;131(14):758-61. doi: 10.1055/s-2006-933728.
6
[Cardiovascular benefit confirmed].[心血管益处得到证实]
MMW Fortschr Med. 2016 Apr 14;158(7):74. doi: 10.1007/s15006-016-8077-4.
7
Hypertension: treating the patient as well as the blood pressure.高血压：治疗患者以及控制血压。
Int J Clin Pract. 2003 Jun;57(5):357.
8
From the Editor.来自编辑
J Am Soc Hypertens. 2017 Mar;11(3):131. doi: 10.1016/j.jash.2017.01.005. Epub 2017 Feb 2.
9
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.血管紧张素转换酶抑制剂、钙拮抗剂及其他降压药物的作用：前瞻性设计的随机试验综述结果。降压治疗试验协作组
Lancet. 2000 Dec 9;356(9246):1955-64. doi: 10.1016/s0140-6736(00)03307-9.
10
Do pharmacologic differences among antihypertensive agents point to clinical benefits?抗高血压药物之间的药理学差异是否意味着临床益处？
Am J Cardiol. 1999 Nov 18;84(10A):22S-27S. doi: 10.1016/s0002-9149(99)00730-4.
本文引用的文献
1
Management of blood pressure in primary care.
BMJ. 2009 May 19;338:b940. doi: 10.1136/bmj.b940.
2
3
Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial.接受降压治疗患者的长期监测：来自安慰剂对照随机对照试验的数据分析
BMJ. 2009 Apr 30;338:b1492. doi: 10.1136/bmj.b1492.
4
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.一种复方制剂（Polycap）对无心血管疾病中年个体危险因素的影响（TIPS）：一项II期双盲随机试验。
Lancet. 2009 Apr 18;373(9672):1341-51. doi: 10.1016/S0140-6736(09)60611-5. Epub 2009 Mar 30.
5
Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.心血管疾病一级和二级预防的风险评估与血脂调整：英国国家卫生与临床优化研究所指南摘要
BMJ. 2008 May 31;336(7655):1246-8. doi: 10.1136/bmj.39554.624086.AD.
6
2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2007年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
Blood Press. 2007;16(3):135-232. doi: 10.1080/08037050701461084.
7
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.降低胆固醇治疗的疗效与安全性：对他汀类药物14项随机试验中90,056名参与者数据的前瞻性荟萃分析
Lancet. 2005 Oct 8;366(9493):1267-78. doi: 10.1016/S0140-6736(05)67394-1. Epub 2005 Sep 27.
8
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.抗高血压药物对冠心病且血压正常患者心血管事件的影响：CAMELOT研究：一项随机对照试验
JAMA. 2004 Nov 10;292(18):2217-25. doi: 10.1001/jama.292.18.2217.
9
Comparison of methods to identify individuals at increased risk of coronary disease from the general population.从普通人群中识别冠心病风险增加个体的方法比较。
BMJ. 2003 Jun 28;326(7404):1436. doi: 10.1136/bmj.326.7404.1436.
10
A strategy to reduce cardiovascular disease by more than 80%.一种将心血管疾病减少80%以上的策略。
BMJ. 2003 Jun 28;326(7404):1419. doi: 10.1136/bmj.326.7404.1419.
Zotero 插件